Presentation Information
[P-55]COVID-19 mRNAワクチン接種者およびウイルス感染回復者において誘導される抗体応答の特性の違い
*Shintaro Oishi1,2, Ryutaro Kotaki1,3, Hisham M Dokainish1, Saya Moriyama1, Shinichiro Ota4, Takayuki Matsumura1, Tomohiro Takano1, Taishi Onodera1, Yu Adachi1, Kazutaka Terahara1, Masanori Isogawa5, Kazuhiko Katayama2, Takashi Sato6, Masaharu Shinkai4, Yoshimasa Takahashi1 (1. Research Center for Vaccine Development, National Institute of Infectious Diseases, Japan Institute for Health Security, 2. Laboratory of Viral Infection Control, Department of Infection Control and Immunology, Ōmura Satoshi Memorial Institute & Graduate School of Infection Control Sciences, Kitasato University, 3. Department of Molecular Systems Immunology, University of Tokyo Pandemic Preparedness, Infection, and Advanced Research Center (UTOPIA), 4. Respiratory Disease Center, Tokyo Shinagawa Hospital, 5. Department of Virology II, National Institute of Infectious Diseases, Japan Institute for Health Security, 6. Institute for Aqua Regeneration, Shinshu University, Nagano)